Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Endocrine

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12020-017-1412-4PMID 28905202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection

  2017cited by this paper
• Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009–2015

  2017cited by this paper
• IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.

  2017cited by this paper
• Oral liquid levothyroxine solves the problem of tablet levothyroxine malabsorption due to concomitant intake of multiple drugs

  2017cited by this paper
• Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.

  2017cited by this paper
• Liquid and softgel levothyroxine use in clinical practice: state of the art

  2016cited by this paper
• The Importance of Reporting Unexpected Drug Failure

  2016cited by this paper
• Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients

  2016cited by this paper
• Treatment of hypothyroidism: all that glitters is gold?

  2016cited by this paper
• Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series

  2016cited by this paper
• TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation

  2016cited by this paper
• What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database.

  2016cited by this paper
• Thyroxine softgel capsule in patients with gastric-related T4 malabsorption

  2015cited by this paper
• The effect of antiepileptic drugs on thyroid hormonal function: causes and implications

  2015cited by this paper
• Drug Interactions with Levothyroxine Therapy in Patients with Hypothyroidism: Observational Study in General Practice

  2015cited by this paper
• Frequent Follow-Up Visits Reduce Weight Regain in Long-Term Management After Bariatric Surgery

  2015cited by this paper
• Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS)

  2015cited by this paper
• The administration of l-thyroxine as soft gel capsule or liquid solution

  2014cited by this paper
• The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy

  2014cited by this paper
• Levothyroxine absorption in health and disease, and new therapeutic perspectives.

  2014cited by this paper
• Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.

  2014cited by this paper
• Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.

  2014cited by this paper
• Prevalence and Incidence of Epilepsy in Italy Based on a Nationwide Database

  2014cited by this paper
• Oral Liquid l-Thyroxine (l-T4) May Be Better Absorbed Compared to l-T4 Tablets Following Bariatric Surgery

  2013cited by this paper
• Progesterone therapy increases free thyroxine levels—data from a randomized placebo‐controlled 12‐week hot flush trial

  2013cited by this paper
• Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism.

  2013cited by this paper
• Atypical celiac disease as cause of increased need for thyroxine: a systematic study.

  2012cited by this paper
• A Population‐Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin

  2012cited by this paper
• Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association

  2012cited by this paper
• The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption.

  2012cited by this paper
• Pharmacokinetics and Potential Advantages of a New Oral Solution of Levothyroxine vs. other Available Dosage Forms

  2012cited by this paper
• Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study

  2012cited by this paper
• Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care.

  2012cited by this paper
• Treatment for primary hypothyroidism: current approaches and future possibilities

  2011cited by this paper
• Update on subclinical hyperthyroidism.

  2011cited by this paper
• Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial.

  2010cited by this paper
• Minireview: thyroid hormone transporters: the knowns and the unknowns.

  2010cited by this paper
• A systematic review of drug absorption following bariatric surgery and its theoretical implications

  2010cited by this paper
• Timing of levothyroxine administration affects serum thyrotropin concentration.

  2009cited by this paper
• Drugs that suppress TSH or cause central hypothyroidism.

  2009cited by this paper
• Conditions and drugs interfering with thyroxine absorption.

  2009cited by this paper
• A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry.

  2009cited by this paper
• The Effect of Famotidine, Esomeprazole, and Ezetimibe on Levothyroxine Absorption

  2008cited by this paper
• Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.

  2007cited by this paper
• Effect of phosphate binders upon TSH and l-thyroxine dose in patients on thyroid replacement

  2007cited by this paper
• Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy.

  2006cited by this paper
• Comparative bioavailability of different formulations of levothyroxine and liothyronine in healthy volunteers

  2006cited by this paper
• Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.

  2006cited by this paper
• Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases.

  2003cited by this paper
• Estrogen, thyroxine binding in serum, and thyroxine therapy.

  2001cited by this paper
• Confounding by indication: an example of variation in the use of epidemiologic terminology.

  1999cited by this paper
• Delayed Intestinal Absorption of Levothyroxine

  1995cited by this paper
• Localization of Human Thyroxine Absorption

  1991cited by this paper
• An overview of issues related to the correction of non-differential exposure measurement error in epidemiologic studies.

  1989cited by this paper

• Developing a machine learning-based predictive model for levothyroxine dosage estimation in hypothyroid patients: a retrospective study

  2025cites this paper
• PROTON-PUMP INHIBITORS DO NOT AFFECT THE BIOAVAILABILITY OF A NOVEL LIQUID FORMULATION OF LEVOTHYROXINE.

  2024cites this paper
• Levothyroxine personalized treatment: is it still a dream?

  2024cites this paper
• SIMULTANEOUS INTAKE OF LIQUID L-T4 FORMULATION AND IRON SALT: FACT OR FICTION?

  2023cites this paper
• Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism

  2022cites this paper
• Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption

  2022cites this paper
• Reduced effectiveness among β-lactam antibiotics: a population-based cohort study in primary care in Italy.

  2021cites this paper
• Effectiveness of ibuprofen plus paracetamol combination on persistence of acute musculoskeletal disorders in primary care patients

  2021cites this paper
• Determinants of HCV‐related complications in Italian primary care patients

  2021cites this paper
• Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults

  2021cites this paper
• Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution

  2019cites this paper
• Electronic Health Record Databases

  2019cites this paper
• Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care

  2019cites this paper
• Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly

  2019cites this paper
• Overview on the management of diverticular disease by Italian General Practitioners.

  2019cites this paper
• Pharmacokinetics and Comparative Bioavailability of a Levothyroxine Sodium Oral Solution and Soft Capsule

  2018cites this paper
• Prescribing patterns of allopurinol and febuxostat according to directives on the reimbursement criteria and clinical guidelines: analysis of a primary care database

  2018cites this paper